Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00807209 · ClinicalTrials.gov registry record · Phase 2
Dose Finding Posterolateral Thoracotomy Study
A Phase 2 study, sponsored by Pacira Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00807209 is a Phase 2 study that was terminated before completion, run by Pacira Pharmaceuticals. The registered enrollment target is 3 participants.
The verdict
NCT00807209, a Phase 2 study, was terminated before completion, sponsored by Pacira Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
To review safety and effectiveness of two doses compared to current standard of care.
Interventions
- DRUG Placebo
- DRUG Low Dose SKY0402
- DRUG High Dose SKY0402
- DRUG Fentanyl via PCA
- DRUG Bupivacaine via epidural
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00807209
The ClinicalTrials.gov registry entry for NCT00807209 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00807209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00807209 about?
NCT00807209 is a clinical study titled "Dose Finding Posterolateral Thoracotomy Study". To review safety and effectiveness of two doses compared to current standard of care.
What is the current status of trial NCT00807209?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2008-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00807209?
The interventions under investigation include: Placebo (DRUG), Low Dose SKY0402 (DRUG), High Dose SKY0402 (DRUG), Fentanyl via PCA (DRUG), Bupivacaine via epidural (DRUG).
Who is sponsoring clinical trial NCT00807209?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.